Data / Form D filings / Trethera Corp
Trethera Corp: Form D filings
Trethera Corp, a biotechnology company in Sherman Oaks, CA, filed 10 Form D notices with the SEC between 2015 and 2025. The latest, on May 2, 2025, reports $250,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 13547 Ventura Blvd., Suite 363, Sherman Oaks, CA, 91423
- Phone
- (310) 997-2788
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1639837
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| May 2, 2025 | New notice | $5,000,000 | $250,000 | $4,750,000 | 1 | Apr 29, 2025 | sec.gov |
| May 17, 2022 | New notice | Indefinite | $3,833,592 | 38 | Jun 26, 2021 | sec.gov | |
| Feb 24, 2021 | New notice | $3,253,368 | $3,253,368 | 25 | Feb 25, 2020 | sec.gov | |
| Apr 17, 2019 | New notice | $10,000,000 | $580,500 | $9,419,500 | 5 | Apr 5, 2019 | sec.gov |
| Mar 11, 2019 | New notice | $8,056,505 | $8,056,505 | 28 | Mar 8, 2019 | sec.gov | |
| Mar 7, 2017 | New notice | $5,000,667 | $4,175,557 | $825,110 | 19 | Feb 23, 2017 | sec.gov |
| Oct 20, 2016 | Amendment | $20,000,000 | $10,049,743 | $9,950,257 | 43 | Feb 10, 2016 | sec.gov |
| Feb 23, 2016 | New notice | $10,016,681 | $7,400,453 | $2,616,228 | 40 | Feb 10, 2016 | sec.gov |
| Jul 2, 2015 | Amendment | $6,006,000 | $4,854,850 | $1,151,150 | 26 | Apr 10, 2015 | sec.gov |
| Apr 17, 2015 | New notice | $4,004,000 | $800,000 | $3,204,000 | 4 | Apr 10, 2015 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Louis L. Gonda | Director | |
| Kenneth A. Schultz, M.D. | Executive Officer, Director | |
| Laurent Boyd Dubois | Director | |
| Carl McKinzie | Director | |
| Timothy Donahue, M.D. | Director | |
| R. Boyd Quinnell | Director |
Other biotechnology companies in California that filed recently
- Trellis Bioscience, Inc. $9.1 million · Oct 29, 2026
- BigHat Biosciences, Inc. $75.1 million · Oct 26, 2026
- Theravie Pharma, Inc. $750,000 · Oct 19, 2026
- Adela, Inc. $12 million · Oct 19, 2026
- Estuary Biotherapeutics, Inc. $40.7 million · Oct 16, 2026
- Renue Life Sciences, Inc. $250,000 · Oct 14, 2026
Every Form D from the week of Apr 28, 2025 · All recent filings in California · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trethera Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.